Conventional and molecular cytogenetic studies to characterize 2 complex variant Philadelphia translocations in patients with chronic myeloid leukemia

  • Authors:
    • Dolors Costa
    • Javier Grau
    • Blanca Espinet
    • Amparo Arias
    • Cándida Gómez
    • Mónica López-Guerra
    • Meritxell Nomdedeu
    • Francisco Cervantes
  • View Affiliations

  • Published online on: April 12, 2019     https://doi.org/10.3892/ol.2019.10245
  • Pages: 5705-5710
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

BCR/ABL1 gene fusion is the hallmark of chronic myeloid leukemia (CML), and is generated in 5-10% of patients by a variant translocation involving 9q34, 22q11.2 and one or more additional genomic regions. The objective of the present study was to characterize, by conventional and molecular cytogenetics, 32 complex variant Philadelphia (Ph) translocations present at diagnosis in patients with CML. The chromosomes most frequently involved were 1 and 5, and the breakpoint most frequently involved was 12p13. The q-chromosome arm was more frequently involved (60%) than the p-arm. The breakpoints were located in the G-light bands in the majority of cases (85%). Additional chromosomal abnormalities were observed in 6 out of 32 (19%) patients. In conclusion, the combination of conventional and molecular cytogenetics studies has allowed us to: i) Detect and quantify the BCR/ABL1 fusion gene; ii) characterize the complex variant translocations and detect cryptic translocations; iii) confirm that the breakpoints are commonly localized in the G-light bands; (iv) confirm that the genesis of variant translocations could be via either the one-step or two-step mechanisms; and v) to report new cases of complex variant translocations.

References

1 

Heim S and Mitelman F: Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells. (4th). Wiley-Blackwell. (New Jersey). 2015. View Article : Google Scholar

2 

Johansson B, Fioretos T and Mitelman F: Cytogenetic and molecular genetic evolution of Philadelphia-chromosome-positive chronic myeloid leukaemia. Chronic Myeloproliferative Disorders. Cytogenetic and molecular genetic abnormalities. Bain BJ: Karger. (Basel). 44–61. 2003.

3 

Mitelman F, Johansson B and Mertens F: Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. simplehttp://cgap.nci.nih.gov/Chromosomes/Mitelman

4 

McGowan-Jordan J, Simons A and Schmid M: ISCN 2016: An International System for Human Cytogenomic Nomenclature. Karger. (Basel). 2016.

5 

Costa D, Carrió A, Madrigal I, Arias A, Valera A, Colomer D, Aguilar JL, Teixido M, Camós M, Cervantes F, et al: Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia. Cancer Genet Cytogenet. 166:89–93. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, Gottardi E, Rambaldi A, Dotti G, Griesinger F, et al: Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia. 13:1901–1928. 1999. View Article : Google Scholar : PubMed/NCBI

7 

Atlas of Genetics and Cytogenetics in Oncology and Haematology. simplehttp://atlasgeneticsoncology.orgMarch 26–2018

8 

Fisher AM, Strike P, Scott C and Moorman AV: Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome. Genes Chromosomes Cancer. 43:383–389. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Gorusu M, Benn P, Li Z and Fang M: On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet. 173:97–106. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Bennour A, Sennana H, Laatiri MA, Elloumi M, Khelif A and Saad A: Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: Genesis and deletion of derivative chromosome 9. Cancer Genet Cytogenet. 194:30–37. 2009. View Article : Google Scholar : PubMed/NCBI

11 

Bennour A, Saad A and Sennana H: Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays. Crit Rev Oncol Hematol. 97:263–274. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Costa, D., Grau, J., Espinet, B., Arias, A., Gómez, C., López-Guerra, M. ... Cervantes, F. (2019). Conventional and molecular cytogenetic studies to characterize 2 complex variant Philadelphia translocations in patients with chronic myeloid leukemia. Oncology Letters, 17, 5705-5710. https://doi.org/10.3892/ol.2019.10245
MLA
Costa, D., Grau, J., Espinet, B., Arias, A., Gómez, C., López-Guerra, M., Nomdedeu, M., Cervantes, F."Conventional and molecular cytogenetic studies to characterize 2 complex variant Philadelphia translocations in patients with chronic myeloid leukemia". Oncology Letters 17.6 (2019): 5705-5710.
Chicago
Costa, D., Grau, J., Espinet, B., Arias, A., Gómez, C., López-Guerra, M., Nomdedeu, M., Cervantes, F."Conventional and molecular cytogenetic studies to characterize 2 complex variant Philadelphia translocations in patients with chronic myeloid leukemia". Oncology Letters 17, no. 6 (2019): 5705-5710. https://doi.org/10.3892/ol.2019.10245